Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Talking to a speaker may boost mood in Parkinson's

NCT ID NCT06036771

Symptom relief Sponsor: The Hong Kong Polytechnic University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tested whether using a voice-activated smart speaker (Apple HomePod mini) could improve psychosocial well-being in 48 people with Parkinson's disease. Participants in the intervention group received a user protocol, the device, training, and tech support for 8 weeks. The study measured sense of coherence, loneliness, and quality of life to see if the approach is feasible and promising.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Apple HomePod mini (voice-activated smart speaker)
What this could lead to
If it works, this could offer a simple, non-drug way to help people with Parkinson's feel less lonely and more in control of their daily lives.
What could go wrong
This is a very small pilot study (48 people) testing feasibility, not effectiveness. The results may not apply to everyone, and the device only supports Cantonese, limiting its reach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

48 people

The number who actually took part.

Started

Aug 2023

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Cantonese-speaking Hong Kong permanent resident * Diagnosed with Parkinson's disease * Level 1-4 in the H\&Y scale (Hoehn \& Yahr, 1967) * Not currently using or owning VIPA * Has stable Wi-Fi connection at home. Exclusion Criteria: * PWP or their caregivers that fails to provide valid consent * Individuals with hearing loss in both ears * Severe voice impairment * Dementia patients (MoCA score \<21) * PWP will leave Hong Kong during the intervention period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parkinson's disease and parkinsonism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parkinson disease parkinsonian disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Parkinson's disease and parkinsonism

Contacts and locations

Locations

  • The Hong Kong Polytechnic University

    Kowloon, Hong Kong, 0000, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.